HighTower Advisors’s Aethlon Medical AEMD Stock Holding History

HighTower Advisors’s Portfolio AEMD Stock Details AEMD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q3	–	Sell	-1	Closed	-$5K	–	2408
2019 Q2	$5K	Hold	1	–	–	﹤0.01%	2316
2019 Q1	$13K	Hold	1	–	–	﹤0.01%	2196
2018 Q4	$19K	Buy	+1	New	+$14.5K	﹤0.01%	2090

Other funds holding AEMD

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CFN

Cordasco Financial Network Naples, Florida $138M AUM 10.5% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

CCA

Cobblestone Capital Advisors Rochester, New York $2.08B AUM 17.27% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

CWAG

Compton Wealth Advisory Group Virginia Beach, Virginia $449M AUM 19.77% 1-Year Est. Return

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

DADC

D.A. Davidson & Co Great Falls, Montana $16.5B AUM 19.94% 1-Year Est. Return

HighTower Advisors's AEMD Position: Q3 2019 in Review

HighTower Advisors sold out of Aethlon Medical (AEMD) in Q3 2019, closing a stake of 1 share — an estimated $5K sold.

HighTower Advisors first reported a position in AEMD in Q4 2018 and held it in 3 quarters. The position peaked at $19K in Q4 2018. 13 funds tracked by Wall St. Rank hold AEMD as of Q3 2019.

HighTower Advisors reported no remaining Aethlon Medical position as of Q3 2019 after selling out during the quarter.
HighTower Advisors sold 1 Aethlon Medical share in Q3 2019, an estimated $5K.
HighTower Advisors first reported a position in Aethlon Medical in Q4 2018 and held it in 3 quarters.
HighTower Advisors's Aethlon Medical position peaked at $19K in Q4 2018.
13 funds tracked by Wall St. Rank held Aethlon Medical as of Q3 2019.

Based on HighTower Advisors's 13F filing for Q3 2019, filed 12 Nov 2019.